N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide

C51H64N12O13S2 — CID 73345556

IUPACN-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide
SMILESCC(C)[C@H]1C(=O)OC[C@H](NC(=O)c2cnc3ccccc3n2)C(=O)N[C@@H](C)C(=O)N(C)[C@H]2CSC(S(C)=O)[C@@H](C(=O)N1C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c1cnc3ccccc3n1)COC(=O)[C@H](C(C)C)N(C)C2=O
InChIInChI=1S/C51H64N12O13S2/c1-25(2)38-49(72)75-22-36(59-42(65)34-21-53-30-17-13-15-19-32(30)57-34)44(67)55-28(6)46(69)63(10)40-48(71)62(9)39(26(3)4)50(73)76-23-35(58-41(64)33-20-52-29-16-12-14-18-31(29)56-33)43(66)54-27(5)45(68)60(7)37(47(70)61(38)8)24-77-51(40)78(11)74/h12-21,25-28,35-40,51H,22-24H2,1-11H3,(H,54,66)(H,55,67)(H,58,64)(H,59,65)/t27-,28-,35-,36-,37-,38-,39-,40+,51?,78?/m0/s1
InChIKeyKDMQZXVLHCCADG-KVHOGBKQSA-N
MW1117.28 g/mol
LogP-0.35
Rot. Bonds7

About N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide

N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide (PubChem CID 73345556) has the molecular formula C51H64N12O13S2 and a molecular weight of 1117.28 g/mol. Its IUPAC name is N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide.

Molecular Properties

Compound NameN-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide
PubChem CID73345556
Molecular FormulaC51H64N12O13S2
Molecular Weight1117.28 g/mol
Exact Mass1116.42
IUPAC NameN-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide
SMILESCC(C)[C@H]1C(=O)OC[C@H](NC(=O)c2cnc3ccccc3n2)C(=O)N[C@@H](C)C(=O)N(C)[C@H]2CSC(S(C)=O)[C@@H](C(=O)N1C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c1cnc3ccccc3n1)COC(=O)[C@H](C(C)C)N(C)C2=O
InChIInChI=1S/C51H64N12O13S2/c1-25(2)38-49(72)75-22-36(59-42(65)34-21-53-30-17-13-15-19-32(30)57-34)44(67)55-28(6)46(69)63(10)40-48(71)62(9)39(26(3)4)50(73)76-23-35(58-41(64)33-20-52-29-16-12-14-18-31(29)56-33)43(66)54-27(5)45(68)60(7)37(47(70)61(38)8)24-77-51(40)78(11)74/h12-21,25-28,35-40,51H,22-24H2,1-11H3,(H,54,66)(H,55,67)(H,58,64)(H,59,65)/t27-,28-,35-,36-,37-,38-,39-,40+,51?,78?/m0/s1
InChIKeyKDMQZXVLHCCADG-KVHOGBKQSA-N
XLogP-0.35
TPSA318.87 Ų
H-Bond Donors4
H-Bond Acceptors18
Rotatable Bonds7
Heavy Atoms78
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001117.28
LogP ≤ 5-0.35
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1018

Analyze N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide?
The IUPAC name of N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide (CID 73345556) is N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide.
What is the SMILES notation for N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide?
The canonical SMILES for N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide is CC(C)[C@H]1C(=O)OC[C@H](NC(=O)c2cnc3ccccc3n2)C(=O)N[C@@H](C)C(=O)N(C)[C@H]2CSC(S(C)=O)[C@@H](C(=O)N1C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)c1cnc3ccccc3n1)COC(=O)[C@H](C(C)C)N(C)C2=O.
What is the InChIKey of N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide?
The InChIKey is KDMQZXVLHCCADG-KVHOGBKQSA-N. The full InChI is InChI=1S/C51H64N12O13S2/c1-25(2)38-49(72)75-22-36(59-42(65)34-21-53-30-17-13-15-19-32(30)57-34)44(67)55-28(6)46(69)63(10)40-48(71)62(9)39(26(3)4)50(73)76-23-35(58-41(64)33-20-52-29-16-12-14-18-31(29)56-33)43(66)54-27(5)45(68)60(7)37(47(70)61(38)8)24-77-51(40)78(11)74/h12-21,25-28,35-40,51H,22-24H2,1-11H3,(H,54,66)(H,55,67)(H,58,64)(H,59,65)/t27-,28-,35-,36-,37-,38-,39-,40+,51?,78?/m0/s1.
What are the key properties of N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide?
N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide has a molecular weight of 1117.28 g/mol, XLogP of -0.35, 7 rotatable bonds, 4 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R,4S,7S,11S,14R,17S,20S,24S)-2,4,12,15,17,25-hexamethyl-27-methylsulfinyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide is sourced from PubChem (CID 73345556), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).